Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2001
12/27/2001WO2001097831A1 Preventives or remedies for heart failure
12/27/2001WO2001097829A2 Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
12/27/2001WO2001097810A2 Use of therapeutic benzamide derivatives
12/27/2001WO2001097809A2 Method of treating cardiovascular disease using rapamycin
12/27/2001WO2001097807A1 New use of angiotensin ii antagonists
12/27/2001WO2001097805A2 Solid valsartan pharmaceutical compositions
12/27/2001WO2001097793A2 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
12/27/2001WO2001097788A2 Method of administering bisphosphonates
12/27/2001WO2001097787A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
12/27/2001WO2001097751A2 New formulation comprising a betablocker and optionally a cholesterol-lowering agent
12/27/2001WO2001085719A9 Ortho-substituted anthranilic acid amides and their use as medicaments
12/27/2001WO2001064645A3 Derivatives of quinoline as alpha-2 antagonists
12/27/2001WO2001053268A3 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation
12/27/2001WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity
12/27/2001WO2001047941A3 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use
12/27/2001WO2001046256A3 Vesicle trafficking proteins
12/27/2001WO2001034614A3 Compositions and methods for double-targeting virus infections and targeting cancer cells
12/27/2001WO2001023390A3 Azepinoindole derivatives, the production and use thereof
12/27/2001WO2001021159A3 Pharmaceutical composition of nateglinide and another antidiabetcagent
12/27/2001WO2000064485A3 Specifically targeted catalytic antagonists and uses thereof
12/27/2001WO2000055109A9 Lipoxin compounds and their use
12/27/2001US20010056211 Adrenergic blocking agent
12/27/2001US20010056184 Pipecolinic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds
12/27/2001US20010056183 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/27/2001US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12
12/27/2001US20010056108 Nitric oxide scavengers, such as dithiocarbamate-containing compounds, are used to reduce side effects caused by therapeutical administration of nitric oxide sources
12/27/2001US20010056105 Useful as cosmetic for hair and body hygiene, and for treatment of dermatological complaints, with an inflammatory and/or immunoallergic component of rheumatic or respiratory type, cardivascular and opthalmogical disorders
12/27/2001US20010056102 Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same
12/27/2001US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases
12/27/2001US20010056099 Method of reducing morbidity and the risk of mortality
12/27/2001US20010056096 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives
12/27/2001US20010056092 Diaminocyclobutene-3,4-dione derivatives, their preparation and use
12/27/2001US20010056081 Treatment of cerebrovascular disease
12/27/2001US20010055629 Extraction
12/27/2001CA2805216A1 Antigenic polypeptides from staphylococcus
12/27/2001CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/27/2001CA2414020A1 Methods and compositions for the treatment of peripheral artery disease
12/27/2001CA2414010A1 Secreted redox proteins
12/27/2001CA2413974A1 Neuroactive peptides for treatment of hypoxia and related conditions
12/27/2001CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
12/27/2001CA2413754A1 Canine hepatocyte growth factor
12/27/2001CA2413556A1 Positively-charged peptide nucleic acid analogs with improved properties
12/27/2001CA2413454A1 A g-protein coupled receptor
12/27/2001CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists
12/27/2001CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/27/2001CA2413418A1 Piperidine amides as modulators of chemokine receptor activity
12/27/2001CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
12/27/2001CA2413277A1 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
12/27/2001CA2413252A1 Preventives or remedies for heart failure
12/27/2001CA2412734A1 Renal regulatory elements and methods of use thereof
12/27/2001CA2412636A1 Method of treating cardiovascular disease using rapamycin
12/27/2001CA2412484A1 G-protein coupled receptors
12/27/2001CA2412215A1 Angiogenesis-modulating compositions and uses
12/27/2001CA2412188A1 3-azabicyclo¬3.1.0|hexane derivatives useful in therapy
12/27/2001CA2412011A1 Chemically-modified antimicrobial peptides, compositions and methods of production and use
12/27/2001CA2411865A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
12/27/2001CA2411585A1 Novel non-psychotropic cannabinoids
12/27/2001CA2411553A1 New use of angiotensin ii antagonists
12/27/2001CA2411236A1 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
12/27/2001CA2411100A1 New formulation comprising a betablocker and optionally a cholesterol-lowering agent
12/27/2001CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/27/2001CA2410447A1 Bis-arylsulfones
12/27/2001CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
12/27/2001CA2409781A1 Phosphodiesterases
12/27/2001CA2409778A1 Secreted proteins
12/27/2001CA2409776A1 G-protein coupled receptors
12/26/2001CN1328566A Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
12/26/2001CN1328554A Eletriptan hydrobromide monohydrate
12/26/2001CN1328552A Pyrimidone derivatives
12/26/2001CN1328549A Substituted benzo [de] isoquinoline-1,3-diones
12/26/2001CN1328548A Benzamide derivatives as thrombin inhibitors
12/26/2001CN1328545A Hydrazine derivatives
12/26/2001CN1328538A 2,4-pentadienoic acid derivatives having selective activity for retinoid X(RXR) receptors
12/26/2001CN1328469A Use of parvovirus capsid particles in inhibition of cell proliferation and migration
12/26/2001CN1328466A Use of antifungal agents for treating scleroses
12/26/2001CN1328462A Use of staurosporine derivatives for treating ocular neovascular diseases
12/26/2001CN1328460A Pharmaceutical combination preparations
12/26/2001CN1328454A Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
12/26/2001CN1328453A Pharmaceutical composition comprising combination of dextro-and laevo-isomers of sotalol
12/26/2001CN1328449A Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as coating agent, binding agent and/or as film-forming auxiliary agent in pharmaceutical for
12/26/2001CN1328417A Compositions and methods for treatment of mitochondrial diseases
12/26/2001CN1327852A Chinese medicine for treating coronary heart disease, reducing blood fat and improving sleep and its preparing process
12/26/2001CN1327850A American ginseng extract (CNT-2000) without residual agricultural chemical and its usage
12/26/2001CN1327835A Medicine for treating cerebral thrombus and its preparing process
12/26/2001CN1327833A Exterior-applied ointment for treating piles
12/26/2001CN1327820A Lotion for treating anal diseases
12/26/2001CN1327814A Chinese medicine for treating coronary heart disease and angina pectoris and its preparing process
12/26/2001CN1327812A Process for preparing medicine to treat apoplexy hemiplegia
12/26/2001CN1327811A Active component of fleabane flower and its preparing process and preparation
12/26/2001CN1327806A Compound Cijin capsule
12/26/2001CN1327803A Chinese-medicinal tea for treating piles and its preparing process
12/26/2001CN1327799A Mixture of white pepper and borneol and its application
12/26/2001CN1327797A Process for preparing medicine to treat cerebral thrombus and its sequelae
12/26/2001CN1327793A Pyrrolo-triazine and pyrimidine compounds
12/26/2001CN1076624C Nasally administrable compositions
12/26/2001CN1076596C Tartaric acid nutritious honey capable of balancing blood pressure
12/26/2001CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate
12/25/2001US6333402 For therapy and diagnosis
12/25/2001US6333354 Synergistic combination of PDE inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
12/25/2001US6333349 Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them
1 ... 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 ... 1595